Environmental fluoxetine promotes skin cell proliferation and wound healing.

Fluoxetine Keratinocyte Serotonin Skin Wound healing

Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 18 06 2024
revised: 21 08 2024
accepted: 12 09 2024
pubmed: 15 9 2024
medline: 15 9 2024
entrez: 14 9 2024
Statut: aheadofprint

Résumé

This study investigates the effects of environmentally-relevant concentrations of fluoxetine (FLX, commercial name: Prozac) on wound healing. Pollution of water systems with pharmaceutical and personal care products, including antidepressants such as FLX and other selective serotonin reuptake inhibitors, is a growing environmental concern. Environmentally-relevant FLX concentrations are known to impact physiological functions and behaviour of aquatic animals, however, the effects of exposure on humans are currently unknown. Using a combination of human skin biopsies and a human keratinocyte cell line, we show that exposure to environmental FLX promotes wound closure. We show dose-dependent increases in wound closure with FLX concentrations from 125 ng/l. Using several -omics and pharmaceutical approaches, we demonstrate that the mechanisms underlying enhanced wound closure are increased cell proliferation and serotonin signalling. Transcriptomic analysis revealed 350 differentially expressed genes after exposure. Downregulated genes were enriched in pathways related to mitochondrial function and metabolism, while upregulated genes were associated with cell proliferation and tissue morphogenesis. Kinase profiling showed altered phosphorylation of kinases linked to the MAPK pathway. Consistent with this, phosphoproteomic analyses identified 235 differentially phosphorylated proteins after exposure, with enriched GO terms related to cell cycle, division, and protein biosynthesis. Treatment of skin biopsies and keratinocytes with ketanserin, a serotonin receptor antagonist, reversed the increase in wound closure observed upon exposure. These findings collectively show that exposure to environmental FLX promotes wound healing through modulating serotonin signalling, gene expression and protein phosphorylation, leading to enhanced cell proliferation. Our results justify a transition from the study of behavioural effects of environmental FLX in aquatic animals to the investigation of effects of exposure on wound healing in aquatic and terrestrial animals, including direct impacts on human health.

Identifiants

pubmed: 39277126
pii: S0269-7491(24)01666-X
doi: 10.1016/j.envpol.2024.124952
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124952

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Quentin Rodriguez-Barucg (Q)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Angel A Garcia (AA)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Belen Garcia-Merino (B)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK; Department of Chemical and Biomolecular Engineering, ETSIIT, University of Cantabria, Av Castros s/n, 39005, Santander, Spain.

Tomilayo Akinmola (T)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Temisanren Okotie-Eboh (T)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Thomas Francis (T)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Eugenio Bringas (E)

Department of Chemical and Biomolecular Engineering, ETSIIT, University of Cantabria, Av Castros s/n, 39005, Santander, Spain.

Inmaculada Ortiz (I)

Department of Chemical and Biomolecular Engineering, ETSIIT, University of Cantabria, Av Castros s/n, 39005, Santander, Spain.

Mark A Wade (MA)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Adam Dowle (A)

Metabolomics & Proteomics Laboratory, Bioscience Technology Facility, Department of Biology, University of York, Wentworth Way, York, YO10 5DD, UK.

Domino A Joyce (DA)

Evolutionary and Ecological Genomics Group, School of Natural Sciences, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Matthew J Hardman (MJ)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Holly N Wilkinson (HN)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK.

Pedro Beltran-Alvarez (P)

Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Cottingham Rd, HU6 7RX, Hull, UK. Electronic address: p.beltran-alvarez@hull.ac.uk.

Classifications MeSH